Purpose: To review the incidence, underlying pathophysiology, and clinical features of filamentary keratitis and to identify evidence-based best-practice strategies for managing filamentary keratitis.
Methods: A comprehensive review of published literature was undertaken. Recommendations for best-practice management strategies were based on the available evidence. Three cases are presented to illustrate the clinical findings and management of patients with chronic filamentary keratitis.
Results: Although the evidence base is limited by the absence of well-designed studies, current evidence indicates the following: (1) Aqueous-deficient dry eye (keratoconjunctivitis sicca) is the most common ocular condition associated with filamentary keratitis. (2) Current best-practice management of filamentary keratitis involves treating the underlying dry eye and specific treatments for the corneal filaments. Proposed treatments include nonpreserved lubricants, topical steroidal and nonsteroidal anti-inflammatory agents, and punctal plugs for aqueous-deficient dry eye as well as mechanical removal of filaments, hypertonic saline, mucolytic agents, and bandage contact lenses for the filaments. (3) Filamentary keratitis can be induced or exacerbated by contact lens wear and ocular surgical procedures such as cataract surgery and corneal graft surgery. Pre- and postoperative ocular surface management strategies should be considered in the surgical planning of patients with, or who are susceptible to, filamentary keratitis. Filamentary keratitis can also be induced and/or exacerbated by chronic use of ocular and/or systemic medications, and alternate medications or additional measures to manage the tear film and ocular surface may be required in these cases.
Conclusions: Filamentary keratitis can be a chronic, recurrent, and debilitating condition. With a systemic approach to diagnosis and management, the condition can be effectively controlled and the incidence and severity of recurrences minimized.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00006324-200306000-00007 | DOI Listing |
Medicina (Kaunas)
October 2024
Department of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy.
Life (Basel)
October 2024
Division of Rheumatology, A.O.U. "Policlinico-San Marco", 95123 Catania, Italy.
Ocul Immunol Inflamm
December 2024
Wilmer Eye Institute, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Ocul Surf
October 2024
Cornea & Anterior Segment Service, L V Prasad Eye Institute, Bhubaneswar, Odisha, 751024, India. Electronic address:
Filamentary keratitis (FK) is a clinical sign of underlying ocular and systemic conditions. FK can cause significant irritation, tearing, and photophobia in the eye. It is a refractory debilitating condition caused by dry eye that affects the day-to-day activities of patients.
View Article and Find Full Text PDFClin Ophthalmol
May 2024
Corneao- Plastic Unit, Queen Victoria Hospital, East Grinsted, West Sussex, UK.
Purpose: To report the outcomes of using a sutureless human amniotic membrane dehydrated matrix (HAMDM) in the management of a range of ocular surface conditions utilizing a digital ocular surface disease assessment tool.
Methods: Two UK NHS Trusts - Queen Victoria Hospital Foundation Trust (East Grinstead and Maidstone) and Tunbridge Wells Trust (Kent) - prospectively treated patients with ocular surface disease with sutureless HAMDM. The patient cohort was assessed for resolution of epithelial defects, ocular surface inflammation, and best-corrected visual acuity pre- and posttreatment.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!